Back to the main directory
EarningsReview / Equity
- Novatek Microelectronics (3034 TT) by HSBC
- Flows set to reaccelerate by BNP Paribas Exane
- South 32 Limited (S32 LN) by HSBC
- Cautious view into FY results by BNP Paribas Exane
- A conservative 2019 guidance by BNP Paribas Exane
- Whitbread : Bonnes nouvelles sur les retours de cash et le plan d’efficience opérationnelle by Oddo BHF
- Strong music momentum drives healthy growth by BNP Paribas Exane
- Delivered by BNP Paribas Exane
- Odfjell (Buy, TP: NOK40.00) - Grab a ticket to ride by DnB Markets
- INVEST SECURITIES - RENAULT : Toujours très décotée, résiste mieux que Nissan - ACHAT, OC 102€ (vs 104€) by Invest Securities
- Whitbread : Good news on cash returns and the operating efficiency plan by Oddo BHF
- BioArctic (Buy, TP: SEK206.00) - Strong end to a strong year by DnB Markets
- Alligator Bioscience (Buy, TP: SEK42.00) - It takes time but it’s honest work by DnB Markets
- Wallenius Wilhelmsen ASA (Buy, TP: NOK45.00) - Bottoming out by DnB Markets
- Hufvudstaden (Sell, TP: SEK138.00) - In-line Q4, still-high valuations by DnB Markets
- Seafood - The Fat Trout Weekly by DnB Markets
- Bravida (Buy, TP: SEK89.00) - Solid quarterly development by DnB Markets
- Star Bulk Minor model adjustments by DnB Markets
- Underappreciated delivery by BNP Paribas Exane
- Hemfosa (Hold, TP: SEK80.00) - Q4 beat, but DPS guidance lowered by DnB Markets
- The weekly navigator by DnB Markets
- Gemalto: Weak mix drives soft underlying performance by BNP Paribas Exane
- AZN (+), MRK (NR), PFE (NR): New Trials that caught our eye! by BNP Paribas Exane
- A Partner for growth by BNP Paribas Exane
- US Healthcare: reality check by BNP Paribas Exane